CORRESP 1 filename1.htm IntelGenx Technologies Corp.: CORRESP - Filed by newsfilecorp.com

January 30, 2020
Via EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Healthcare & Insurance

Attn: Ada D. Sarmento

100 F Street, N.E.

Washington, D.C.  20549

 

Re: Request for Acceleration - IntelGenx Technologies Corp.

Amendment No. 1 to Registration Statement on Form S-1

(SEC File No. 333-235607)

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, IntelGenx Technologies Corp. (the "Company"), respectfully requests that the Commission accelerate the effectiveness of the above-referenced Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-235607), and permit said Registration Statement to become effective at 4:00 p.m. (Eastern Time) on January 31, 2020, or as soon thereafter as practicable. 

The Company hereby authorizes James Guttman, an attorney with our outside legal counsel, Dorsey & Whitney LLP, to orally modify or withdraw this request for acceleration.

Please contact James Guttman of Dorsey & Whitney LLP at (416) 367-7376 with any questions with respect to this request.

  Sincerely,
   
  IntelGenx Technologies Corp.
   
  /s/ Andre Godin
   
  Andre Godin
  President and Chief Financial Officer

cc: James Guttman, Dorsey & Whitney LLP

    Richard Raymer, Dorsey & Whitney LLP